Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage. (otvara se novi prozor)

Brady KM, Easley RB, Tobias JD.

Izvor‎: Paediatr Anaesth 2006;16(10):1042-6.

Indeks‎: PubMed 16972833

DOI‎: 10.1111/j.1460-9592.2006.02039.x

https://www.ncbi.nlm.nih.gov/pubmed/16972833 (otvara se novi prozor)

The use of recombinant activated factor VII in the treatment of massive pulmonary hemorrhage in a preterm infant. (otvara se novi prozor)

Cetin H, Yalaz M, Akisu M, Karapinar DY, Kavakli K, Kultursay N.

Izvor‎: Blood Coagul Fibrinolysis 2006;17(3):213-6.

Indeks‎: PubMed 16575260

DOI‎: 10.1097/01.mbc.0000220245.20036.2d

https://www.ncbi.nlm.nih.gov/pubmed/16575260 (otvara se novi prozor)

The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy. (otvara se novi prozor)

Chuansumrit A, Nuntnarumit P, Okascharoen C, Teeraratkul S, Suwansingh S, Supapannachart S.

Izvor‎: Pediatrics 2002;110(1 Pt 1):169-71.

Indeks‎: PubMed 12093965

https://www.ncbi.nlm.nih.gov/pubmed/12093965 (otvara se novi prozor)

Recombinant activated factor VIIa (rFVIIa) treatment in very-low-birth-weight (VLBW) premature infants with acute pulmonary hemorrhage: a single-center, retrospective study. (otvara se novi prozor)

Cosar H, Isik H, Cakır SC, Yar N, Goksen B, Tokbay H, Kertmen H, Erdoğan N, Durak I.

Izvor‎: Paediatr Drugs 2017;19(1):53-8.

Indeks‎: PubMed 27826851

DOI‎: 10.1007/s40272-016-0203-3

https://www.ncbi.nlm.nih.gov/pubmed/27826851 (otvara se novi prozor)

Recombinant activated factor VIIa treatment for refractory hemorrhage in infants. (otvara se novi prozor)

Dang CN, Katakam LI, Smith PB, Cotten CM, Goldberg RN, Chandler N, Thornburg CD, Bidegain M.

Izvor‎: J Perinatol 2011;31(3):188-92.

Indeks‎: PubMed 20671714

DOI‎: 10.1038/jp.2010.85

https://www.ncbi.nlm.nih.gov/pubmed/20671714 (otvara se novi prozor)

Use of recombinant factor VIIa in infants with severe coagulopathy. (otvara se novi prozor)

Fontaine MJ, Lazarchick J, Taylor S, Annibale D.

Izvor‎: J Perinatol 2004;24(5):310-1.

Indeks‎: PubMed 15116125

DOI‎: 10.1038/sj.jp.7211086

https://www.ncbi.nlm.nih.gov/pubmed/15116125 (otvara se novi prozor)

Predicting response to rFVIIa in neonates with intractable bleeding or severe coagulation disturbances. (otvara se novi prozor)

Gkiougki E, Mitsiakos G, Chatziioannidis E, Papadakis E, Nikolaidis N.

Izvor‎: J Pediatr Hematol Oncol 2013;35(3):221-6.

Indeks‎: PubMed 23511491

DOI‎: 10.1097/MPH.0b013e318286d27e

https://www.ncbi.nlm.nih.gov/pubmed/23511491 (otvara se novi prozor)

Successful use of recombinant activated FVII and aminocaproic acid in four neonates with life-threatening hemorrhage. (otvara se novi prozor)

Grizelj R, Vuković J, Filipović-Grčić B, Šarić D, Luetić T.

Izvor‎: Blood Coagul Fibrinolysis 2006;17(5):413-5.

Indeks‎: PubMed 16788319

DOI‎: 10.1097/01.mbc.0000233373.71970.6f

https://www.ncbi.nlm.nih.gov/pubmed/16788319 (otvara se novi prozor)

Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. (otvara se novi prozor)

Guzzetta NA, Huch S, Fernandez JD, Tosone SR, Miller BE.

Izvor‎: Paediatr Anaesth 2009;19(4):364-70.

Indeks‎: PubMed 19143947

DOI‎: 10.1111/j.1460-9592.2008.02905.x

https://www.ncbi.nlm.nih.gov/pubmed/19143947 (otvara se novi prozor)

The use of recombinant factor VIIa for severe intractable bleeding during spine surgery. (otvara se novi prozor)

Kaw LL Jr, Coimbra R, Potenza BM, Garfin SR, Hoyt DB.

Izvor‎: Spine 2004;29(12):1384-7.

Indeks‎: PubMed 15187645

https://www.ncbi.nlm.nih.gov/pubmed/15187645 (otvara se novi prozor)

Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases. (otvara se novi prozor)

Mitsiakos G, Papaioannou G, Giougi E, Karagianni P, Garipidou V, Nikolaidis N.

Izvor‎: J Pediatr Hematol Oncol 2007;29(3):145-50.

Indeks‎: PubMed 17356391

DOI‎: 10.1097/MPH.0b013e3180335bcb

https://www.ncbi.nlm.nih.gov/pubmed/17356391 (otvara se novi prozor)

Treatment of severe pulmonary hemorrhage with activated recombinant factor VII (rFVIIa) in very low birth weight infants. (otvara se novi prozor)

Olomu N, Kulkarni R, Manco-Johnson M.

Izvor‎: J Perinatol 2002;22(8):672-4.

Indeks‎: PubMed 12478454

DOI‎: 10.1038/sj.jp.7210787

https://www.ncbi.nlm.nih.gov/pubmed/12478454 (otvara se novi prozor)

Thrombotic events in neonates receiving recombinant factor VIIa or fresh frozen plasma. (otvara se novi prozor)

Puetz J, Darling G, Brabec P, Blatny J, Mathew P.

Izvor‎: Pediatr Blood Cancer 2009;53(6):1074-8.

Indeks‎: PubMed 19621430

DOI‎: 10.1002/pbc.22160

https://www.ncbi.nlm.nih.gov/pubmed/19621430 (otvara se novi prozor)